ZA921270B - Peptides for treatment - Google Patents
Peptides for treatmentInfo
- Publication number
- ZA921270B ZA921270B ZA921270A ZA921270A ZA921270B ZA 921270 B ZA921270 B ZA 921270B ZA 921270 A ZA921270 A ZA 921270A ZA 921270 A ZA921270 A ZA 921270A ZA 921270 B ZA921270 B ZA 921270B
- Authority
- ZA
- South Africa
- Prior art keywords
- absent
- thr
- ser
- gly
- cys
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK031991A DK31991D0 (da) | 1991-02-25 | 1991-02-25 | Peptid og farmaceutisk praeparat indeholdende et saadant peptid |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA921270B true ZA921270B (en) | 1992-11-25 |
Family
ID=8092219
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA921270A ZA921270B (en) | 1991-02-25 | 1992-02-21 | Peptides for treatment |
Country Status (13)
Country | Link |
---|---|
US (1) | US5763406A (de) |
EP (1) | EP0573538B1 (de) |
JP (1) | JP3250804B2 (de) |
AT (1) | ATE118349T1 (de) |
AU (1) | AU1377092A (de) |
CA (1) | CA2101075C (de) |
DE (1) | DE69201438T2 (de) |
DK (2) | DK31991D0 (de) |
ES (1) | ES2070635T3 (de) |
GR (1) | GR3015888T3 (de) |
IE (1) | IE69853B1 (de) |
WO (1) | WO1992014751A1 (de) |
ZA (1) | ZA921270B (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739109A (en) * | 1988-12-16 | 1998-04-14 | Advanced Immunit Inc. | Method of treating neuroinflammatory degenerative diseases |
US5593967A (en) * | 1990-08-31 | 1997-01-14 | Warner-Lambert Company | Cholecystokinin antagonists, their preparation and therapeutic use |
WO1995008338A1 (en) * | 1993-09-24 | 1995-03-30 | Peptide Technology Limited | Method for the treatment or prevention of eczema/dermatitis |
US6458766B1 (en) * | 1998-12-15 | 2002-10-01 | The Regents Of The University Of California | Halovir, an antiviral marine natural product, and derivatives thereof |
US6613507B1 (en) | 2000-03-21 | 2003-09-02 | Yu-an Chang | Boraadamantane compounds for the treatment of pathogenic viruses and other medical applications |
US7374068B2 (en) * | 2004-10-08 | 2008-05-20 | Homax Products, Inc. | Particulate materials for acoustic texture material |
MY159500A (en) * | 2009-05-22 | 2017-01-13 | Genocea Biosciences Inc | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
WO2012074881A2 (en) | 2010-11-24 | 2012-06-07 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
US20130189754A1 (en) | 2011-09-12 | 2013-07-25 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
EP2586461A1 (de) | 2011-10-27 | 2013-05-01 | Christopher L. Parks | Von einem eingehüllten Virus abgeleitete Virenpartikel |
WO2013078299A1 (en) | 2011-11-23 | 2013-05-30 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
US9347065B2 (en) | 2012-03-29 | 2016-05-24 | International Aids Vaccine Initiative | Methods to improve vector expression and genetic stability |
ES2444299B1 (es) | 2012-08-23 | 2014-12-12 | Nutrición Técnica Deportiva, S.L. | Uso de un hidrolizado de caseina como agente antiherpético |
JP2019537555A (ja) | 2016-09-28 | 2019-12-26 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | ヘルペスを処置するための方法および組成物 |
EP4308170A1 (de) | 2021-03-18 | 2024-01-24 | Seagen Inc. | Selektive wirkstofffreisetzung aus internalisierten konjugaten biologisch aktiver verbindungen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0190127A1 (de) * | 1984-08-10 | 1986-08-13 | MERCK PATENT GmbH | Immunotherapeutische polypeptidheilmittel |
US4585587A (en) * | 1984-10-19 | 1986-04-29 | Northwestern University | Antigenic peptide compounds |
IT1190433B (it) * | 1985-12-11 | 1988-02-16 | Prodotti Antibiotici Spa | Peptidi correlati al lisozima |
WO1987007614A1 (en) * | 1986-06-03 | 1987-12-17 | Pert Candace B | Small peptides which inhibit binding to t-4 receptors |
ATE96450T1 (de) * | 1986-06-03 | 1993-11-15 | Us Commerce | Kleine peptide, die die bindung an t-4-rezeptoren inhibieren und als immunogene wirken. |
AU1808088A (en) * | 1987-05-22 | 1988-12-21 | Syntbiotech, Inc. | Synthetic peptides and a method of treating aids |
WO1989012067A1 (en) * | 1988-05-27 | 1989-12-14 | The United States Of America, As Represented By Th | Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
DE3841761A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
GB8905606D0 (en) * | 1989-03-11 | 1989-04-26 | Scras | Peptides |
-
1991
- 1991-02-25 DK DK031991A patent/DK31991D0/da not_active Application Discontinuation
-
1992
- 1992-02-17 IE IE920496A patent/IE69853B1/en not_active IP Right Cessation
- 1992-02-21 ZA ZA921270A patent/ZA921270B/xx unknown
- 1992-02-24 DK DK92906394.9T patent/DK0573538T3/da active
- 1992-02-24 WO PCT/DK1992/000053 patent/WO1992014751A1/en active IP Right Grant
- 1992-02-24 AT AT92906394T patent/ATE118349T1/de active
- 1992-02-24 JP JP50548192A patent/JP3250804B2/ja not_active Expired - Fee Related
- 1992-02-24 CA CA002101075A patent/CA2101075C/en not_active Expired - Fee Related
- 1992-02-24 AU AU13770/92A patent/AU1377092A/en not_active Abandoned
- 1992-02-24 ES ES92906394T patent/ES2070635T3/es not_active Expired - Lifetime
- 1992-02-24 DE DE69201438T patent/DE69201438T2/de not_active Expired - Fee Related
- 1992-02-24 EP EP92906394A patent/EP0573538B1/de not_active Expired - Lifetime
-
1995
- 1995-04-19 GR GR950401025T patent/GR3015888T3/el unknown
- 1995-06-07 US US08/481,840 patent/US5763406A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DK0573538T3 (da) | 1995-06-26 |
DE69201438D1 (en) | 1995-03-23 |
JPH06507386A (ja) | 1994-08-25 |
GR3015888T3 (en) | 1995-07-31 |
US5763406A (en) | 1998-06-09 |
DK31991D0 (da) | 1991-02-25 |
ATE118349T1 (de) | 1995-03-15 |
AU1377092A (en) | 1992-09-15 |
CA2101075C (en) | 2003-04-22 |
EP0573538A1 (de) | 1993-12-15 |
IE920496A1 (en) | 1992-08-26 |
WO1992014751A1 (en) | 1992-09-03 |
CA2101075A1 (en) | 1992-08-26 |
DE69201438T2 (de) | 1995-10-05 |
ES2070635T3 (es) | 1995-06-01 |
EP0573538B1 (de) | 1995-02-15 |
IE69853B1 (en) | 1996-10-02 |
JP3250804B2 (ja) | 2002-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA921270B (en) | Peptides for treatment | |
EP1077070A3 (de) | Orale Darreichungsform | |
NZ502872A (en) | Mevinolin and compaction as LFA-1 antagonists for treating autoimmune diseases | |
MD1652F2 (en) | Protein possessing the cytokin - type activity, recombinant DNA-codifyer for such protein, transformed cells and microorganism, expression vector, process for protein obtaining and remedy containing such a protein | |
ZA9394B (en) | A novel human kunitz-type inhibitor and variants thereof | |
HK1160778A1 (en) | Pharmaceutical composition comprising an analgesic peptide | |
ATE386118T1 (de) | Cnp-gen und vorläuferprotein aus schwein | |
CA2002924A1 (en) | Anti-Thrombins | |
YU29596A (sh) | Genski proizvodi koji regulišu gojaznost | |
CA2025070A1 (en) | Recombinant aprotinin variants genetically engineered process for the microbial preparation of homgeneously processed aprotinin variants and the therapeutic use thereof | |
AU671989B2 (en) | Treatment of tropical spastic paresis with peptide T | |
CA2196308A1 (en) | Peptide, bronchodilator and blood flow ameliorant | |
ATE124955T1 (de) | Substrat-peptide. | |
AU6354298A (en) | Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis | |
HK1013622A1 (en) | Pharmaceutical lysine-containing polypeptide compositions and the use thereof | |
EP0687685A4 (de) | Physiologisch-aktive peptide | |
EP0248231A3 (en) | Pharmacologically active peptides | |
CA2216704A1 (en) | Novel peptides and remedy for bone diseases containing the same as active ingredient | |
RU94046096A (ru) | Линейные или циклические пептиды, их применение, способы лечения и конъюгаты пептидов | |
ATE106088T1 (de) | Peptide und deren verwendung in der therapie. | |
CA2102447A1 (en) | Cyclopeptides | |
RU94036002A (ru) | Ингибитор протеазы, днк, вектор, клетка, способ получения ингибитора, фармацевтическая композиция |